Colistin heteroresistance in acinetobacter and its association with previous colistin therapy
- PMID: 17954699
- PMCID: PMC2223915
- DOI: 10.1128/AAC.00766-07
Colistin heteroresistance in acinetobacter and its association with previous colistin therapy
Abstract
Colistin heteroresistance has been reported among Acinetobacter isolates; however, its association with prior colistin therapy has not been not described. A population analysis profile identified resistant Acinetobacter subpopulations from colistin-susceptible clinical isolates. The proportion of cells exhibiting heteroresistance was significantly higher among isolates recovered from patients treated with colistin.
References
-
- Albrecht, M. A., M. E. Griffith, C. K. Murray, K. K. Chung, E. E. Horvath, J. A. Ward, D. R. Hospenthal, J. B. Holcomb, and S. E. Wolf. 2006. Impact of Acinetobacter infection on the mortality of burn patients. J. Am. Coll. Surg. 203:546-550. - PubMed
-
- Reference deleted.
-
- Clinical and Laboratory Standards Institute. 2006. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
-
- Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; sixteenth informational supplement. CLSI document M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
